Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Klaria Pharma Holding

Klaria Pharma Holding
2015 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
KLAR STOCK SYMBOL
3 INVESTMENTS
$0.54 SHARE PRICE (As of Monday Closing)
Description

Klaria Pharma Holding AB is engaged in the development and commercialization of pharmaceutical products in Sweden for migraine and cancer-related pain. Its operations are based on a patented drug delivery platform in the form of an alginate-based polymer film.

Website
Formerly Known As
Annodam AB
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Drug Discovery
Other Industries
Therapeutic Devices
Drug Delivery
Stock Exchange
STO
Primary Office
  • Virdings Allé 2
  • 754 50 Uppsala
  • Sweden

+46 08-446 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Klaria Pharma Holding’s full profile, request a free trial.

Klaria Pharma Holding Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.43 - $1.61 $17.7M $0.55 -$0.09 20.1K 32.1M

Klaria Pharma Holding Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 23,665 31,973 33,257 24,169
Revenue 434 0 266 0
EBITDA (1,617) (2,039) (1,411) (1,690)
Net Income (2,711) (3,138) (2,524) (1,698)
Total Assets 11,250 11,821 15,190 17,791
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Klaria Pharma Holding Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Klaria Pharma Holding‘s full profile, request access.

Request full access to PitchBook

Klaria Pharma Holding Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000000000 000 05-Nov-2019 000000000000000000 Drug Delivery 00000 00000
000 000000000000 19-Sep-2019 000000 00 000000 Discovery Tools (Healthcare) 00000 00000
Karessa Pharma Holding Merger/Acquisition Drug Discovery 00000 00000
To view this company’s complete investment and acquisition history, request access »

Klaria Pharma Holding Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Klaria Pharma Holding‘s full profile, request access.

Request full access to PitchBook

Klaria Pharma Holding Executive Team (3)

Name Title Board
Seat
Contact
Info
Scott Boyer Chief Executive Officer & Director
Hans Richter Chief Financial Officer
Leif Ingemarsson Chief Technology Officer